Literature DB >> 8069586

The Caco-2 cell monolayers as an intestinal metabolism model: metabolism of dipeptide Phe-Pro.

M Hu1, J Chen, D Tran, Y Zhu, G Leonardo.   

Abstract

The metabolism of Phe-Pro was investigated in Caco-2 cell monolayers, a model of small intestinal epithelium. The results indicate that the majority of Phe-Pro was hydrolyzed during passage from the apical (AP) to basolateral (BL) side. The enzyme responsible for the hydrolysis is prolidase, a cytosolic enzyme. Through kinetic studies of a supernatant enzyme preparation, a Km of 30.4 microM and Vmax of 38.9 nmol/min per mg of protein were obtained. The enzyme catalyzed hydrolysis was inhibited by proline (66%), Zn+ (86%), Cu++ (100%), Fe (100%), PCMB (89%), and captopril (66%), but not by leucine. We also studied the transcellular transport of Phe-Pro by measuring the amount of Phe in the receiver media. In the presence of a proton gradient (AP pH6, BL pH7.4), the appearance rate of Phe in the BL media after Phe-Pro was loaded apically was at least 100 times faster than that in the AP media after Phe-Pro was loaded basolaterally. The former is also higher than the appearance rate of Phe without a transepithelial proton gradient (pH 6-pH 6) or against a proton gradient (pH7.4-pH6). The rate of appearance of Phe in the BL media (pH7.4) after Phe-Pro was loaded on the AP side (pH 6) was decreased by the presence in the AP media of proline (42%), leucine (40%), and captopril (17%), but not by Zn++. In conclusion, the transmembrane uptake of Phe-Pro is dependent on a proton gradient, and the intracellular metabolism of Phe-Pro is complete via hydrolysis by prolidase.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8069586     DOI: 10.3109/10611869409015895

Source DB:  PubMed          Journal:  J Drug Target        ISSN: 1026-7158            Impact factor:   5.121


  10 in total

1.  Use of glucuronidation fingerprinting to describe and predict mono- and dihydroxyflavone metabolism by recombinant UGT isoforms and human intestinal and liver microsomes.

Authors:  Lan Tang; Ling Ye; Rashim Singh; Baojian Wu; Chang Lv; Jie Zhao; Zhongqiu Liu; Ming Hu
Journal:  Mol Pharm       Date:  2010-06-07       Impact factor: 4.939

2.  Development and validation of an UPLC-MS/MS method for the quantification of columbin in biological matrices: Applications to absorption, metabolism, and pharmacokinetic studies.

Authors:  Guangyi Yang; Song Gao; Rongjin Sun; Taijun Yin; Ming Hu
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2015-08-07       Impact factor: 3.205

3.  Development of Caco-2 cells expressing high levels of cDNA-derived cytochrome P4503A4.

Authors:  C L Crespi; B W Penman; M Hu
Journal:  Pharm Res       Date:  1996-11       Impact factor: 4.200

4.  Mechanism and kinetics of transcellular transport of a new beta-lactam antibiotic loracarbef across an intestinal epithelial membrane model system (Caco-2).

Authors:  M Hu; J Chen; Y Zhu; A H Dantzig; R E Stratford; M T Kuhfeld
Journal:  Pharm Res       Date:  1994-10       Impact factor: 4.200

5.  Variable isoflavone content of red clover products affects intestinal disposition of biochanin A, formononetin, genistein, and daidzein.

Authors:  Stephen W J Wang; Yan Chen; Tiby Joseph; Ming Hu
Journal:  J Altern Complement Med       Date:  2008-04       Impact factor: 2.579

6.  Inhibition of P-glycoprotein leads to improved oral bioavailability of compound K, an anticancer metabolite of red ginseng extract produced by gut microflora.

Authors:  Zhen Yang; Jing-Rong Wang; Tao Niu; Song Gao; Taijun Yin; Ming You; Zhi-Hong Jiang; Ming Hu
Journal:  Drug Metab Dispos       Date:  2012-05-14       Impact factor: 3.922

7.  Determination of osthol and its metabolites in a phase I reaction system and the Caco-2 cell model by HPLC-UV and LC-MS/MS.

Authors:  Zhenting Yuan; Haiyan Xu; Ke Wang; Zhonghua Zhao; Ming Hu
Journal:  J Pharm Biomed Anal       Date:  2008-12-09       Impact factor: 3.935

8.  Biopharmaceutical and pharmacokinetic characterization of matrine as determined by a sensitive and robust UPLC-MS/MS method.

Authors:  Zhen Yang; Song Gao; Taijun Yin; Kaustubh H Kulkarni; Yang Teng; Ming You; Ming Hu
Journal:  J Pharm Biomed Anal       Date:  2009-11-26       Impact factor: 3.935

9.  Mechanisms responsible for poor oral bioavailability of paeoniflorin: Role of intestinal disposition and interactions with sinomenine.

Authors:  Zhong Qiu Liu; Zhi Hong Jiang; Liang Liu; Ming Hu
Journal:  Pharm Res       Date:  2006-10-25       Impact factor: 4.580

10.  Progress in the development of early diagnosis and a drug with unique pharmacology to improve cancer therapy.

Authors:  A Lehotzky; N Tokési; I Gonzalez-Alvarez; V Merino; M Bermejo; F Orosz; P Lau; G G Kovacs; J Ovádi
Journal:  Philos Trans A Math Phys Eng Sci       Date:  2008-10-13       Impact factor: 4.226

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.